Coronary artery disease is the most common form of heart disease and results from atherosclerotic plaque buildup in coronary arteries, reducing blood flow to the heart. It can present with angina, myocardial infarction, heart failure, or sudden cardiac events.
Johnson & Johnson faces new talc verdicts in Minnesota and Pennsylvania totaling over $10 million, with 67,000+ lawsuits pending. Meanwhile, the FDA approved a new monthly dosing for RYBREVANT FASPRO, and the company launched its Shockwave C2 Aero coronary catheter globally.
More cancer survivors are living long enough to face lasting cardiovascular effects of treatment. Cardio-oncology clinics are managing heart failure, valvular disease and radiation-related heart disease.
New research shows home-based exercise reduces cognitive impairment during chemotherapy, while cardio-oncology programs monitor and minimize heart complications from cancer treatments that pose cardiovascular risks to survivors.
The FDA has expanded approval of GSK's Arexvy RSV vaccine to include adults aged 18 to 49 years at increased risk for lower respiratory tract disease, based on phase 3b trial data showing noninferior immune response.
New research demonstrates RNA therapies can enhance heart regeneration after injury, while RNA biomarkers improve prediction of cardiovascular complications in chronic kidney disease patients.
The global 3D bioprinted human tissue market is projected to grow from $2.5 billion in 2025 to $3.9 billion by 2035 at a 4.6% CAGR, driven by regenerative medicine demand and advances in hybrid hydrogel materials for tissue engineering.
Recent research shows younger heart disease patients face unique parenting challenges, middle-aged healthy eating protects against cognitive decline, and timing evening meals three hours before bed improves cardiovascular markers.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07592507 |
1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease |
NOT_YET_RECRUITING | PHASE4 |
| NCT07591987 |
Effect of Different Breathing Techniques on Dyspnea and Cardiopulmonary Parameters Among Patients After Open Heart Surgery |
RECRUITING | NA |
| NCT07588399 |
STRATegy SUccesS in High-Risk PCI With Impella CP: Evaluation of Hemodynamic Protection in Complex PCI |
NOT_YET_RECRUITING | NA |
| NCT07582835 |
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. |
RECRUITING | PHASE3 |
| NCT07576569 |
Nursing Intervention for Adaptation After Myocardial Revascularization |
NOT_YET_RECRUITING | NA |
| NCT07570940 |
A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery |
NOT_YET_RECRUITING | PHASE4 |
| NCT07569692 |
PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography-2 |
NOT_YET_RECRUITING | NA |
| NCT07567378 |
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry |
NOT_YET_RECRUITING | |
| NCT07566091 |
Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers |
NOT_YET_RECRUITING | NA |
| NCT07563231 |
ABLUMINUS NP Polymer Free Sirolimus-Eluting Stent Registry at Geneva University Hospitals (ABLUMINUS-GVA) |
NOT_YET_RECRUITING |
